How Enterprise Resilience Drives International Collaboration under Institutional Barriers: Evidence from Chinese Pharmaceutical Export Enterprises
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In the context of rising geopolitical tensions and complex regulatory environments, Chinese pharmaceutical export enterprises face growing institutional barriers that hinder their participation in Global Value Chains (GVCs). Drawing on dynamic capability theory and contingency theory, this study examines how enterprise resilience— comprising anticipatory and adaptive capabilities—facilitates international collaboration under institutional pressure. Using survey data from 319 managerial respondents of Chinese pharmaceutical export enterprises and hierarchical regression analysis, the results show that both anticipatory and adaptive capabilities are positively associated with GVC participation and restructuring. Additionally, the empirical evidence partially supports the proposed moderating effects of institutional barriers—namely institutional distance, institutional uncertainty, and institutional stringency. While these barriers do not significantly affect the relationship between resilience and GVC participation, they selectively weaken its positive relationship with GVC restructuring. These findings suggest the conditional role of enterprise resilience in navigating complex institutional environments and offer preliminary insights for policymakers to improve institutional conditions and mitigate the constraining effects of institutional barriers.
Abstract
In the context of rising geopolitical tensions and complex regulatory environments, Chinese pharmaceutical export enterprises face growing institutional barriers that hinder their participation in Global Value Chains (GVCs). Drawing on dynamic capability theory and contingency theory, this study examines how enterprise resilience— comprising anticipatory and adaptive capabilities—facilitates international collaboration under institutional pressure. Using survey data from 319 managerial respondents of Chinese pharmaceutical export enterprises and hierarchical regression analysis, the results show that both anticipatory and adaptive capabilities are positively associated with GVC participation and restructuring. Additionally, the empirical evidence partially supports the proposed moderating effects of institutional barriers—namely institutional distance, institutional uncertainty, and institutional stringency. While these barriers do not significantly affect the relationship between resilience and GVC participation, they selectively weaken its positive relationship with GVC restructuring. These findings suggest the conditional role of enterprise resilience in navigating complex institutional environments and offer preliminary insights for policymakers to improve institutional conditions and mitigate the constraining effects of institutional barriers.